- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Complex Sclerosing Papillary Lesion of the Breast in Sweden
Total 134 results
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research InstituteActive, not recruitingRelapsing-remitting Multiple SclerosisSweden
-
Karolinska InstitutetRecruitingMultiple SclerosisSweden
-
Karolinska InstitutetCompleted
-
GeNeuro Innovation SASCompleted
-
Anders SvenningssonVästerbotten County Council, SwedenCompletedProgressive Multiple SclerosisSweden
-
Karolinska InstitutetThe Swedish Research Council; ForteCompletedMultiple SclerosisSweden
-
Jan LyckeCompletedMultiple Sclerosis, PharmacokineticsSweden
-
Karolinska InstitutetKarolinska University HospitalRecruitingMultiple Sclerosis | Postural BalanceSweden
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research CouncilCompletedMultiple SclerosisSweden
-
Karolinska InstitutetNeuro+CompletedMultiple Sclerosis | Fatigue | Cytokines | Resistance Training | Exercise TherapySweden
-
Karolinska InstitutetCompletedMultiple Sclerosis | Autologous Mesenchymal Stem CellsSweden
-
BiogenCompleted
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingSweden
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research CouncilCompleted
-
BayerCompletedMultiple Sclerosis | Positron-Emission TomographyAustralia, Sweden
-
BayerWithdrawnMultiple SclerosisSweden, Denmark
-
Karolinska InstitutetKarolinska University HospitalRecruitingMultiple Sclerosis | Aging | Gait Disorders, Neurologic | Neuro-Degenerative DiseaseSweden
-
Haukeland University HospitalRecruitingMultiple SclerosisNorway, Sweden, Denmark, Netherlands
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsActive, not recruitingRelapsing Remitting Multiple SclerosisNorway, Sweden
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Relapsing-RemittingSweden, Germany
-
Anders SvenningssonCompletedMultiple Sclerosis, Relapsing-RemittingSweden
-
Karolinska InstitutetActive, not recruitingMultiple Sclerosis, Relapsing-RemittingSweden
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Uppsala UniversityNot yet recruitingMultiple Sclerosis | InsomniaSweden
-
Otivio ASActive, not recruitingMultiple Sclerosis | Spasticity, Muscle | Pain, ChronicSweden
-
Tomas OlssonThe Swedish Research CouncilRecruiting
-
GlaxoSmithKlineCompletedMultiple SclerosisBelgium, Sweden, Czech Republic, Denmark, Norway
-
EMD SeronoCompleted12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.Multiple SclerosisUnited States, Canada, Germany, Italy, Spain, Sweden
-
BayerCompletedMultiple SclerosisSwitzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
BiogenRecruitingMultiple SclerosisUnited States
-
Bristol-Myers SquibbActive, not recruitingMultiple SclerosisUnited States
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Genzyme, a Sanofi CompanyTerminatedMultiple SclerosisUnited States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Novartis PharmaceuticalsTerminatedMultiple SclerosisBelgium, Spain, Russian Federation, France, Italy, Poland, Sweden, Turkey, Czech Republic, Japan
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompleted
-
BiogenCompletedMultiple SclerosisSweden, United Kingdom, Netherlands, Belgium, Canada, Italy
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
BayerCompletedMultiple SclerosisSwitzerland, France, Germany, Indonesia, Korea, Republic of, Spain, Sweden, Thailand, Taiwan, Australia, Austria, Colombia, Czech Republic, Italy, Jordan, Kazakhstan, Lebanon, Mexico, Slovenia, United Kingdom, Bahrain, Egypt, United... and more
-
AB ScienceRecruitingProgressive Multiple SclerosisSpain, Sweden, France, Greece, Italy, Poland, Russian Federation, Ukraine
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
BiogenCompletedMultiple SclerosisRussian Federation, Sweden, Germany, Poland, Hungary, United Kingdom, Netherlands, Switzerland, Turkey, Czechia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingSpain, Bulgaria, Ukraine, United Kingdom, Sweden, Germany, Canada, Czech Republic
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more